UNIVERSITY PARK, Pa. — A Penn State microbiologist and the huge collection of bacteria he oversees recently received a four-year, $371,000 grant from the National Science Foundation to be part of a multi-institutional $2.5 million research project aimed at predicting “bacteriophage” resistance from only a genome sequence.
The E. coli Reference Center is housed in the Food Science Department within the College of Agricultural Sciences and includes about 95,000 bacteria samples. With more than 6,200 of its samples genome sequenced, the center is likely the only publicly available collection in the country that could have been leveraged for this particular project, according to Ed Dudley, professor of food science and director of the center.
A bacteriophage is a type of virus that infects bacteria, Dudley explained. In fact, the word "bacteriophage" literally means "bacteria eater," because bacteriophages destroy their host cells. A bacteriophage attaches itself to a susceptible bacterium and infects the host cell. Following infection, the bacteriophage hijacks the bacterium’s cellular machinery to prevent it from producing bacterial components and instead forces the cell to produce viral components.
So-called phage therapy is seen as a possible weapon against multi-drug-resistant strains of many bacteria, Dudley pointed out, adding that phages have been used since the early-to-mid 20th century as an alternative to antibiotics in the former Soviet Union and Central Europe.